These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 19152364)
1. Cytotoxicities and structure-activity relationships of natural and unnatural lamellarins toward cancer cell lines. Chittchang M; Batsomboon P; Ruchirawat S; Ploypradith P ChemMedChem; 2009 Mar; 4(3):457-65. PubMed ID: 19152364 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationship study of potent cytotoxic analogues of the marine alkaloid Lamellarin D. Pla D; Marchal A; Olsen CA; Francesch A; Cuevas C; Albericio F; Alvarez M J Med Chem; 2006 Jun; 49(11):3257-68. PubMed ID: 16722644 [TBL] [Abstract][Full Text] [Related]
3. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues. Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262 [TBL] [Abstract][Full Text] [Related]
4. Anticancer properties of lamellarins. Bailly C Mar Drugs; 2015 Feb; 13(3):1105-23. PubMed ID: 25706633 [TBL] [Abstract][Full Text] [Related]
5. Lamellarins as inhibitors of P-glycoprotein-mediated multidrug resistance in a human colon cancer cell line. Plisson F; Huang XC; Zhang H; Khalil Z; Capon RJ Chem Asian J; 2012 Jun; 7(7):1616-23. PubMed ID: 22473938 [TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Structure-Activity Relationship Studies of Glycosylated Derivatives of Marine Natural Product Lamellarin D. Zheng L; Gao T; Ge Z; Ma Z; Xu J; Ding W; Shen L Eur J Med Chem; 2021 Mar; 214():113226. PubMed ID: 33582387 [TBL] [Abstract][Full Text] [Related]
7. Lamellarin D bioconjugates I: Synthesis and cellular internalization of PEG-derivatives. Pla D; Francesch A; Calvo P; Cuevas C; Aligué R; Albericio F; Alvarez M Bioconjug Chem; 2009 Jun; 20(6):1100-11. PubMed ID: 19472995 [TBL] [Abstract][Full Text] [Related]
8. Total synthesis of natural and unnatural lamellarins with saturated and unsaturated D-rings. Ploypradith P; Petchmanee T; Sahakitpichan P; Litvinas ND; Ruchirawat S J Org Chem; 2006 Dec; 71(25):9440-8. PubMed ID: 17137371 [TBL] [Abstract][Full Text] [Related]
9. Chemistry of Ecteinascidins. Part 5: An Additional Proof of Cytotoxicity Evaluation of Ecteinascidin 770 Derivatives. Toyoshima R; Mori N; Suzuki T; Lowtangkitcharoen W; Suwanborirux K; Saito N Chem Pharm Bull (Tokyo); 2016; 64(7):966-9. PubMed ID: 27373655 [TBL] [Abstract][Full Text] [Related]
10. A high-yielding modular access to the lamellarins: synthesis of lamellarin G trimethyl ether, lamellarin η and dihydrolamellarin η. Imbri D; Tauber J; Opatz T Chemistry; 2013 Nov; 19(45):15080-3. PubMed ID: 24123481 [No Abstract] [Full Text] [Related]
11. Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues: a novel DYRK1A inhibitor class. Neagoie C; Vedrenne E; Buron F; Mérour JY; Rosca S; Bourg S; Lozach O; Meijer L; Baldeyrou B; Lansiaux A; Routier S Eur J Med Chem; 2012 Mar; 49():379-96. PubMed ID: 22305342 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antitumor activity of simplified ecteinascidin-saframycin analogs. Liu ZZ; Wang Y; Tang YF; Chen SZ; Chen XG; Li HY Bioorg Med Chem Lett; 2006 Mar; 16(5):1282-5. PubMed ID: 16338237 [TBL] [Abstract][Full Text] [Related]
13. Lamellarin D bioconjugates II: Synthesis and cellular internalization of dendrimer and nuclear location signal derivatives. Pla D; Martí M; Farrera-Sinfreu J; Pulido D; Francesch A; Calvo P; Cuevas C; Royo M; Aligué R; Albericio F; Alvarez M Bioconjug Chem; 2009 Jun; 20(6):1112-21. PubMed ID: 19472996 [TBL] [Abstract][Full Text] [Related]
14. Design and total synthesis of Mannich derivatives of marine natural product lamellarin D as cytotoxic agents. Shen L; Xie N; Yang B; Hu Y; Zhang Y Eur J Med Chem; 2014 Oct; 85():807-17. PubMed ID: 25189362 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of lamellarin D analogues targeting topoisomerase I. Ohta T; Fukuda T; Ishibashi F; Iwao M J Org Chem; 2009 Nov; 74(21):8143-53. PubMed ID: 19791738 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of novel benzo[6,7]indolo[3,4-c]isoquinolines as anticancer agents with topoisomerase I inhibition. Sakai K; Soshima T; Hirose Y; Ishibashi F; Hirao S Bioorg Med Chem Lett; 2024 May; 104():129710. PubMed ID: 38518997 [TBL] [Abstract][Full Text] [Related]
17. Total synthesis and evaluation of lamellarin alpha 20-Sulfate analogues. Ridley CP; Reddy MV; Rocha G; Bushman FD; Faulkner DJ Bioorg Med Chem; 2002 Oct; 10(10):3285-90. PubMed ID: 12150874 [TBL] [Abstract][Full Text] [Related]
18. Molecular determinants of topoisomerase I poisoning by lamellarins: comparison with camptothecin and structure-activity relationships. Marco E; Laine W; Tardy C; Lansiaux A; Iwao M; Ishibashi F; Bailly C; Gago F J Med Chem; 2005 Jun; 48(11):3796-807. PubMed ID: 15916431 [TBL] [Abstract][Full Text] [Related]
19. Construction of Pentacyclic Lamellarin Skeleton via Grob Reaction: Application to Total Synthesis of Lamellarins H and D. B Manjappa K; Lin JM; Yang DY J Org Chem; 2017 Jul; 82(14):7648-7656. PubMed ID: 28665125 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and topoisomerase I inhibitory activity of a novel diazaindeno[2,1-b]phenanthrene analogue of Lamellarin D. Cananzi S; Merlini L; Artali R; Beretta GL; Zaffaroni N; Dallavalle S Bioorg Med Chem; 2011 Aug; 19(16):4971-84. PubMed ID: 21783369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]